Efficacy and bait acceptance of vaccinia vectored rabies glycoprotein vaccine in captive foxes (Vulpes vulpes), raccoon dogs (Nyctereutes procyonoides) and dogs (Canis familiaris)

Vaccine

Volumn 26, Issue 36, 2008, Pages 4627-4638

  Cliquet, F ^a   Barrat, J ^a   Guiot, A L ^b   Cael N ^a   Boutrand, S ^c   Maki, J ^c   Schumacher, C L ^c  

^a Healthy Pigs Production and Experimentation Section   (France)

^b Conseils en Pharmacie et Biologie ^*  (France)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Dog; Fox; Oral vaccine; Rabies; Raccoon dog

Indexed keywords

NEUTRALIZING ANTIBODY; RABIES VACCINE; RABORAL V RG; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; CONTROLLED STUDY; DOG; DRUG EFFICACY; FEMALE; FOX; INFECTION PREVENTION; MALE; NONHUMAN; PRIORITY JOURNAL; RABIES; RACCOON DOG; REVIEW; SEROCONVERSION; VACCINIA VIRUS; VIRUS RECOMBINANT;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; DISEASE TRANSMISSION, HORIZONTAL; DOG DISEASES; DOGS; FEEDING BEHAVIOR; FOXES; NEUTRALIZATION TESTS; RABIES; RABIES VACCINES; RABIES VIRUS; RACCOON DOGS; VACCINATION; VACCINIA;

EID: 48849102532     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.06.089     Document Type: Review

References (47)

1. WHO expert consultation on rabies, first report. World Health Organization, WHO Technical Report Series 931; 2005. p. 1-87.
2. Kieny M.P., Lathe R., Drillien R., Spehner D., Skory S., Schmitt D., et al. Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature 312 5990 (1984) 163-166
3. Wiktor T.J., Mac Farlan R.I., Reagan K., Dietzschold B., Curtis P., Wunner W.H., et al. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc Natl Acad Sci 81 (1984) 7194
4. Brochier B., Blancou J., Thomas I., Languet B., Artois M., Kieny M.P., et al. Use of recombinant vaccinia-rabies glycoprotein virus for oral vaccination of wildlife against rabies: innocuity to several non-target bait consuming species. J Wildl Dis 25 4 (1989) 540-547
5. Pastoret P.P., Brochier B., Blancou J., Artois M., Aubert M., Kieny M.P., et al. Development and deliberate release of a vaccinia-rabies recombinant virus for the oral vaccination of foxes against rabies. In: Smith G.L., and Binns M. (Eds). Recombinant poxviruses (1992), CRC Press, Boca Raton, FL 163-206
6. Hammami S., Schumacher C.L., Cliquet F., Barrat J., Tlatli A., Ben Osman R., et al. Safety evaluation of the SAG2 rabies virus mutant in Tunisian dogs and several non-target species. Vet Res 30 (1999) 353-362
7. Blancou J., Kieny M.P., Lathe R., Lecocq J.P., Pastoret P.P., Soulebot J.P., et al. Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature 322 (1986) 373-375
8. Chappuis G., Languet B., Duret C., and Desmettre P. Dog rabies vaccination. The use of recombinant poxviruses by oral and parenteral route. Proceedings of the symposium on rabies control in Asia. Jakarta, Indonesia, April 27-30 (1993) 125-137
9. Rupprecht C.E., Hamir A.N., Johnston D.H., and Koprowski H. Efficacy of a vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor). Rev Infect Dis 10 Suppl. 4 (1988) S803-S809
10. Tolson N.D., Charlton K.M., Stewart R.B., Campbell J.B., and Wiktor T.J. Immune response in skunks to a vaccinia virus recombinant expressing the rabies virus glycoprotein. Can J Vet Res 51 3 (1987) 363-366
11. Brochier B., Aubert M.F., Pastoret P.P., Masson E., Schon J., Lombard M., et al. Field use of a vaccinia-rabies recombinant vaccine for the control of sylvatic rabies in Europe and North America. Rev Sci Tech OIE 15 3 (1996) 947-970
12. Roscoe D.E., Holste W.C., Sorhage F.E., Campbell C., Niezgoda M., Buchannan R., et al. Efficacy of an oral vaccinia-rabies glycoprotein recombinant vaccine in controlling epidemic raccoon rabies in New Jersey. J Wildl Dis 34 4 (1998) 752-763
13. Fearneyhough M.G., Wilson P.J., Clark K.A., Smith D.R., Johnston D.H., Hicks B.N., et al. Results of an oral rabies vaccination program for coyotes. JAVMA 212 4 (1998) 498-502
14. Mackowiak M., Maki J., Motes-Kreimeyer L., Harbin T., and Van Kampen K. Vaccination of wildlife against rabies: successful use of a vectored vaccine obtained by recombinant technology. Adv Vet Med 41 (1999) 571-583
15. Sidwa T.J., Wilson P.J., Moore G.M., Oertli E.H., Hicks B.N., Rohde R.E., et al. Evaluation of oral rabies vaccination programs for control of rabies epizootics in coyotes and gray foxes: 1995-2003. JAVMA 227 5 (2005) 785-792
16. Yakobson B.A., King R., Amir S., Devers N., Sheichat N., Rutenberg D., et al. Rabies vaccination programme for red foxes (Vulpes vulpes) and golden jackals (Canis aureus) in Israel (1999-2004). In: Dodet B., Schudel A., Pastoret P.P., and Lombard M. (Eds). First international conference on rabies in Europe (2006), Karger, Basel 133-140
17. Brochier B., Kieny M.P., Costy F., Coppens P., Bauduin B., Lecocq J.P., et al. Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine. Nature 354 (1991) 520-522
18. Brochier B., Costy F., and Pastoret P.P. Elimination of fox rabies from Belgium using a recombinant vaccinia-rabies vaccine: an update. Vet Microbiol 46 1-3 (1995) 269-279
19. Masson E., Aubert M.F., Barrat J., and Vuillaume P. Comparison of the efficacy of the antirabies vaccines used for foxes in France. Vet Res 27 3 (1996) 255-266
20. Aubert M.F.A., Cliquet F., Smak J.A., Brochier B., Schon J., and Kappeler A. Rabies in France, the Netherlands, Belgium, Luxembourg and Switzerland. In: King A., Fooks A.R., Aubert M., and Wandeler A.I. (Eds). Historical perspective of rabies in Europe and the Mediterranean Basin (2004), O.I.E., Paris 129-145
21. Cliquet F., and Aubert M. Elimination of terrestrial rabies in Western European countries. In: Schudel A., and Lombard M. (Eds). Control of infectious animal diseases by vaccination (2004), Karger, Basel 185-204
22. Wandeler A. Epidemiology and ecology of fox rabies in Europe. In: King A., Fooks A.R., Aubert M., and Wandeler A.I. (Eds). Historical perspective of rabies in Europe and the Mediterranean Basin (2004), O.I.E., Paris 201-214
23. Botvinkin A.D., Savitskii V.P., Sidorov G.N., and Iudin V.G. Importance of the raccoon dog in the epidemiology and epizootiology of rabies in the Far East. Zh Mikrobiol Epidemiol Immunobiol 12 (1981) 79-82
24. Milius J., Jacevicius E., Tamosiunas V., Paulauskas V., and Lukauskas K. Rabies among wild and domestic animals in Lithuania in 1993-2002: epizootiology, diagnosis and vaccination. Bull Vet Inst Pulawy 48 (2004) 195-200
25. Meslin F.X., Fishbein D.B., and Matter H.C. Rationale and prospects for rabies elimination in developing countries. In: Rupprecht C.E., Dietzschold B., and Koprowski H. (Eds). Lyssaviruses (1994), Springer-Verlag, Berlin 1-26
26. Directive du conseil, 24 novembre 1986, concernant le rapprochement des dispositions legislatives, réglementaires et administratives des Etats membres relatives à la protection des animaux utilisés à des fins expérimentales ou à d'autres fins scientifiques. JO des Communautés Européennes; 1986 (18 décembre):1.
27. Cliquet F., Aubert M.F.A., and Sagné L. Development of a fluorescent antibody virus neutralizing test (FAVN test) for the quantitation of rabies-neutralizing antibody. J Immunol Methods 212 (1998) 79-87
28. Dean D., and Abelseth M.K. The fluorescent antibody test. In: Meslin F.X., Kaplan M.M., and Koprowski H. (Eds). Laboratory techniques in rabies. 4th ed. (1996), World Health Organisation, Geneva 88-95
29. Barrat J., Barrat M.J., Picard M., and Aubert M.F.A. Diagnostic de la rage sur culture cellulaire. Comparaison des résultats de l'inoculation au neuroblastome murin et de l'inoculation à la souris. Comp Immun Microbiol Infect Dis 11 (1988) 207-214
30. Johnston D.H., Joachim D.G., Bachmann P., Kardong K.V., Stewart R.A., Dix L., et al. In: Nowak M., Baker J.A., Obbard M.E., and Malloch B. (Eds). Aging furbearers using teeth structure and biomarkers (1987), Wildfurbearer management and conservation in North America, Ontario Ministry of Natural Resources, Toronto 228-243
31. Pastoret P.P., Kappeler A., and Aubert M. European rabies control and its history. In: King A., Fooks A.R., Aubert M., and Wandeler A.I. (Eds). Historical perspective of rabies in Europe and the Mediterranean Basin (2004), O.I.E., Paris 337-350
32. Brochier B.M., Languet B., Artois M., Zanker S., Guittre C., Blancou J., et al. Efficacy of a baiting system for vaccinating foxes against rabies with vaccinia-rabies recombinant virus. Vet Rec 127 7 (1990) 165-167
33. Brochier B., Thomas I., Bauduin B., Leveau T., Pastoret P.P., Languet B., et al. Use of a vaccinia-rabies recombinant virus for the oral vaccination of foxes against rabies. Vaccine 8 2 (1990) 101-104
34. Cliquet F., Guiot A.L., Munier M., Bailly J., Rupprecht C.E., and Barrat J. Safety and efficacy of the oral rabies vaccine SAG2 in raccoon dogs. Vaccine 24 20 (2006) 4386-4392
35. Sagarasaeranee P., Puanghat A., Kasempimolporn S., and Khawplod P. Efficacy of oral rabies vaccine in dogs in Thailand. In: Dodet B., and Meslin F.X. (Eds). Proceedings of the symposium rabies control in Asia. John Libbey Eurotext, Paris, March 5-9 (2001) 101-104
36. Artois M., Masson E., Barrat J., and Aubert M.F.A. Efficacy of three oral rabies vaccine baits in the red fox: a comparison. Vet Microbiol 38 (1993) 167-172
37. Black J.G., and Lawson K.F. The efficacy of immunizing foxes (Vulpes vulpes) using bait containing attenuated rabies vaccine. Can J Comp Med 44 (1980) 169-176
38. Kieny M.P., Blancou J., Lathe R., Pastoret P.P., Soulebot J.P., Desmettre P., et al. Development of animal recombinant DNA vaccine and its efficacy in foxes. Rev Infect Dis 10 4 (1988) 799-802
39. Aguilar Setien A., Brochier B., Tordo N., De Paz O., Desmettre P., Peharpre D., et al. Experimental rabies infection and oral vaccination in vampire bats (Desmodus rotundus). Vaccine 16 11-12 (1998) 1122-1126
40. Rupprecht C.E., Shaddock J.S., Sanderlin D.W., Hanlon C.A., Niezgoda M., and Schumacher C.L. Oral rabies vaccination in dogs. Israel J Vet Med 53 4 (1998) 127-131
41. Fekadu M., Nesby S.L., Shaddock J.H., Schumacher C.L., Linhart S.B., and Sanderlin D.W. Immunogenicity, efficacy and safety of an oral rabies vaccine (SAG2) in dogs. Vaccine 14 6 (1996) 465-468
42. Orciari L.A., Niezgoda M., Hanlon C.A., Shaddock J.H., Sanderlin D.W., Yager P.A., et al. Rapid clearance of SAG-2 rabies virus from dogs after oral vaccination. Vaccine 19 (2001) 4511-4518
43. Aubert M., Barrat J., Artois M., and Schumacher C. Efficacy tests of SAG2 on target species. Fourth WHO consultation on oral immunization of dogs against rabies. Geneva, June 14-15 (1993)
44. Cliquet F., Gurbuxani J.P., Pradhan H.K., Pattnaik B., Patil S.S., Regnault A., et al. The safety and efficacy of the oral rabies vaccine SAG2 in Indian stray dogs. Vaccine 25 17 (2007) 3409-3418
45. Lambot M., Blasco E., Barrat J., Cliquet F., Brochier B., Renders C., et al. Humoral and cell-mediated immune responses of foxes (Vulpes vulpes) after experimental primary and secondary oral vaccination using SAG2 and V-RG vaccines. Vaccine 19 13-14 (2001) 1827-1835
46. Alderton D. Foxes, wolves and wild dogs of the world (1998), Blandford Press, UK
47. Blasco E., Lambot M., Barrat J., Cliquet F., Brochier B., Renders C., et al. Kinetics of humoral immune response after rabies VR-G oral vaccination of captive fox cubs (Vulpes vulpes) with or without maternally derived antibodies against the vaccine. Vaccine 19 32 (2001) 4805-4815